Table 1.
Clinical studies targeting recruitment of myeloid cells in patients with COVID-19
TargetIdentifierInterventionsStatusPhaseStart date
CXCL8 (IL-8) NCT04347226 BMS-986253 Recruiting Phase II April 2020 
CCR5 NCT04343651 Leronlimab Recruiting Phase II April 2020 
 NCT04347239 Leronlimab Recruiting Phase II April 2020 
 NCT04441385 Maraviroc Recruiting Phase II June 2020 
 NCT04435522 Maraviroc Not yet recruiting Phase I September 2020 
TargetIdentifierInterventionsStatusPhaseStart date
CXCL8 (IL-8) NCT04347226 BMS-986253 Recruiting Phase II April 2020 
CCR5 NCT04343651 Leronlimab Recruiting Phase II April 2020 
 NCT04347239 Leronlimab Recruiting Phase II April 2020 
 NCT04441385 Maraviroc Recruiting Phase II June 2020 
 NCT04435522 Maraviroc Not yet recruiting Phase I September 2020 

https://www.clinicaltrials.gov; July 14, 2020.

View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal